<p>Method comprises administering immune system-potentiating dose of at least one thymosin or an immune system-potentiating thymosin fragment. The thymosin is pref. Thymosin Fraction Five or Thymosin alpha-1.</p>
申请公布号
GR3024025(T3)
申请公布日期
1997.10.31
申请号
GR19970401680T
申请日期
1997.07.09
申请人
MUTCHNICK, MILTON;SHERMAN, KENNETH E.
发明人
MUTCHNICK, MILTON;CHRETIAN, PAUL;SHERMAN, KENNETH E.
